[HTML][HTML] Pathophysiological basis for nutraceutical supplementation in heart failure: a comprehensive review

V Mollace, GMC Rosano, SD Anker, AJS Coats… - Nutrients, 2021 - mdpi.com
There is evidence demonstrating that heart failure (HF) occurs in 1–2% of the global
population and is often accompanied by comorbidities which contribute to increasing the …

[PDF][PDF] PATHOPHYSIOLOGICAL BASIS FOR NUTRACEUTICAL SUPPLEMENTATION IN HEART FAILURE: A COMPREHENSIVE REVIEW

V Mollace, GMC Rosano, S Anker, AJS Coats… - 2020 - scholar.archive.org
Heart failure (HF) is a disease state which has been shown to affect 1-2% of the global
population, being often associated with comorbidities such as diabetes, hypertension …

Pathophysiological basis for nutraceutical supplementation in heart failure: A comprehensive review

V Mollace, GMC Rosano, SD Anker, AJS Coats… - NUTRIENTS, 2021 - iris.unicz.it
There is evidence demonstrating that heart failure (HF) occurs in 1–2% of the global
population and is often accompanied by comorbidities which contribute to increasing the …

Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review.

V Mollace, GMC Rosano, SD Anker, AJS Coats… - Nutrients, 2021 - europepmc.org
There is evidence demonstrating that heart failure (HF) occurs in 1–2% of the global
population and is often accompanied by comorbidities which contribute to increasing the …

Pathophysiological basis for nutraceutical supplementation in heart failure: a comprehensive review.

V Mollace, GMC Rosano, SD Anker, AJS Coats… - 2021 - cabidigitallibrary.org
There is evidence demonstrating that heart failure (HF) occurs in 1-2% of the global
population and is often accompanied by comorbidities which contribute to increasing the …

Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review.

V Mollace, G Rosano, SD Anker, AJS Coats… - …, 2021 - search.ebscohost.com
There is evidence demonstrating that heart failure (HF) occurs in 1–2% of the global
population and is often accompanied by comorbidities which contribute to increasing the …

Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review

V Mollace, G Rosano, SD Anker, AJS Coats… - 2020 - preprints.org
Heart failure (HF) is a disease state which has been shown to affect 1-2% of the global
population, being often associated with comorbidities such as diabetes, hypertension …

[PDF][PDF] Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review. Nutrients 2021, 13, 257

V Mollace, GMC Rosano, SD Anker, AJS Coats… - 2021 - academia.edu
There is evidence demonstrating that heart failure (HF) occurs in 1–2% of the global
population and is often accompanied by comorbidities which contribute to increasing the …

Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review

V Mollace, G Rosano, SD Anker, AJS Coats… - NUTRIENTS, 2021 - iris.unibs.it
There is evidence demonstrating that heart failure (HF) occurs in 1-2% of the global
population and is often accompanied by comorbidities which contribute to increasing the …

Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review

V Mollace, G Rosano, S Anker, C JSA, P Seferovic… - NUTRIENTS, 2021 - iris.uniroma5.it
There is evidence demonstrating that heart failure (HF) occurs in 1–2% of the global
population and is often accompanied by comorbidities which contribute to increasing the …